| scholarly article | Q13442814 |
| P50 | author | Saba Balasubramanian | Q83234371 |
| P2093 | author name string | Karen Sisley | |
| Sirwan Hadad | |||
| Safar Kheder | |||
| P2860 | cites work | Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade | Q21245891 |
| Thyrotropin Suppression by Metformin | Q22241662 | ||
| Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? | Q22241958 | ||
| AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function | Q26865723 | ||
| Metformin in cancer: translational challenges | Q26866388 | ||
| TOR signaling in growth and metabolism | Q27860757 | ||
| Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells | Q28539104 | ||
| The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin | Q28590162 | ||
| Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
| Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 | Q33602223 | ||
| Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations | Q33845157 | ||
| Understanding the benefit of metformin use in cancer treatment | Q33864199 | ||
| The epidemiology of thyroid disease | Q34213678 | ||
| Metformin and cancer occurrence in insulin-treated type 2 diabetic patients | Q34421989 | ||
| Sulphonylureas and cancer: a case-control study | Q34601902 | ||
| The influence of glucose-lowering therapies on cancer risk in type 2 diabetes | Q34609508 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. | Q35188193 | ||
| Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study | Q35620231 | ||
| Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. | Q35629996 | ||
| Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival | Q35688186 | ||
| No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study. | Q35810943 | ||
| Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells | Q35855395 | ||
| Histone H2A phosphorylation in DNA double-strand break repair | Q36174600 | ||
| Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer | Q36261224 | ||
| TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. | Q37319151 | ||
| New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes | Q37319178 | ||
| Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study | Q37399977 | ||
| Update on recent developments in the therapy of differentiated thyroid cancer | Q37683838 | ||
| Thyroid cancer epidemiology and prognostic variables | Q37772326 | ||
| Metformin: its emerging role in oncology | Q37846987 | ||
| Diabetes mellitus: new drugs for a new epidemic | Q37879307 | ||
| Destabilizing RET in targeted treatment of thyroid cancers | Q38819099 | ||
| Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway | Q38889694 | ||
| Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle | Q39043221 | ||
| Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells. | Q39130053 | ||
| Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. | Q39385860 | ||
| Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents | Q39406069 | ||
| Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions. | Q39485621 | ||
| Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. | Q39547941 | ||
| Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability | Q39592755 | ||
| Atypically low spontaneous sister chromatid exchange formation in uveal melanoma | Q39641986 | ||
| Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro | Q39883174 | ||
| Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells | Q40050621 | ||
| Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark | Q44608163 | ||
| Antidiabetic Drug Metformin Induces Apoptosis in Human MCF Breast Cancer via Targeting ERK Signaling | Q46263878 | ||
| Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study | Q48394963 | ||
| Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. | Q54570063 | ||
| Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. | Q54583667 | ||
| INDUCTION OF NEOPLASMS IN THYROID GLANDS OF RATS BY SUBTOTAL THYROIDECTOMY AND BY THE INJECTION OF ONE MICROCURIE OF I-131 | Q76686181 | ||
| Thyroid-stimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT | Q81098004 | ||
| The role of insulin receptors and IGF-I receptors in cancer and other diseases | Q81238512 | ||
| [Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma] | Q83237703 | ||
| Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes | Q83979505 | ||
| The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus | Q95383722 | ||
| P433 | issue | 6 | |
| P921 | main subject | metformin | Q19484 |
| thyroid cancer | Q826522 | ||
| P304 | page(s) | 1053-1061 | |
| P577 | publication date | 2017-04-09 | |
| P1433 | published in | Journal of Cancer | Q6294901 |
| P1476 | title | Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines | |
| P478 | volume | 8 |
Search more.